Chronic myeloid leukemia following chemotherapy with 5′-deoxy-5-fluorouridine for gastric cancer

Internal Medicine

Volumn 47, Issue 19, 2008, Pages 1739-1741

  Tsuzuki, Motohiro ^a   Handa, Kousuke ^a   Yamamoto, Kiyoko ^a   Hasegawa, Akio ^a   Yamamoto, Yukiya ^a   Watanabe, Masato ^a   Mizuta, Syuichi ^a   Maruyama, Fumio ^a   Okamoto, Masataka ^a   Emi, Nobuhiko ^a   Ezaki, Kohji ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 deoxy 5 fluorouridine; Chronic myeloid leukemia; Gastric cancer; Therapy related leukemia

Indexed keywords

ANTIMETABOLITE; DOXIFLURIDINE; IMATINIB;

ADJUVANT THERAPY; AGED; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DRUG RESPONSE; EDEMA; GASTRECTOMY; HUMAN; LONG TERM CARE; MALE; SIDE EFFECT; STOMACH CANCER; TREATMENT DURATION; WEIGHT GAIN;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; FLOXURIDINE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; NEOPLASMS, SECOND PRIMARY; STOMACH NEOPLASMS; TIME FACTORS;

EID: 56349110929     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1072     Document Type: Article

References (17)

1. Whang-Peng J, Young RC, Lee EC, Longo DL, Schechter GP, DeVita VT. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after treatment modalities. Blood 71: 403-414, 1998.
2. Devereux S. Therapy associated leukemia. Blood Rev 5: 138-145, 1991.
3. Levine EG, Bloomfields CD. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environment exposure. Semin Oncol 19: 47-84, 1992.
4. Shimano S, Maruyama K, Katahira H, Tsuchiya J. A retrospective study of acute myelogenous leukemia and myelodysplastic syndrome cases - clinical and hematological findings-. Jpn J Cancer Clin 40: 175-179, 1994 (in Japanese, Abstract in English).
5. Toyosawa M, Shinohara K, Ando T, Ariyoshi K. Two cases of secondary leukemia presumably caused by administration of anticancer drugs. Jpn J Cancer Clin 42: 319-324, 1996 (in Japanese, Abstract in English).
6. Grunwald HW, Rosner F. Acute leukemia and immunosuppressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseased. Arch Inten Med 139: 461-466, 1979.
7. Hermann C, Andersen E, Videbaek A. Acute myeloblastic leukaemia in sarcoidosis treated with methtrexate. Scand J Haematol 24: 234-236, 1980.
8. Wanders J, Wattendolff AR, Endtz LJ, den Nijs JJ, Leeksma CHW. Chronic myeloid leukemia in myasthenia gravis after long term treatment with 6-mercaptopurine. Acta Med Scand 210: 235-238, 1981.
9. Ishitsuka H, Miwa M, Takemoto K, Fukuoka K, Itoga A, Maruyama HB. Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine. Gann 71: 112-123, 1980.
10. Suzuki Y, Hongu Y, Fukuzawa H, Ichihara S, Shimizu H. Tissue distribution of 5′-deoxy-5-fluorouridine and derived 5-fluorouracil in tumor-bearing mice and rats. Gann 71: 238-245, 1980.
11. Ishiyama T, Sugimoto M, Wakabayashi Y, Hirose S. Chronic myelogenous leukemia following the therapy of early gastric cancer. Rinsho Ketsueki 26: 756-760, 1985 (in Japanese, Abstract in English).
12. Porta C, Casagranda I, Semino G, Morini M, Ratto C. Chronic myeloid leukemia following cyclophosphamide-chemotherapy in a breast cancer patient. Hematologica 78: 56-57, 1993.
13. Nakamura H, Inokuchi K, Hanawa H, et al. A case of chronic myeloid leukemia with minor bcr-abl transcript following fluorouracil therapy for esophageal carcinoma. Ann Hematol 79: 396-401, 2000.
14. Gokel Y, Paydas S. Chronic myeloid leukemia in a patient with colon cancer. Hematologica 32: 501-503, 2002.
15. Uenogawa K, Takeuchi J, Itoh T, et al. Effects of imatinib mesylate for patients with CML after the treatments for malignant diseases. Rinsho Ketsueki 46: 976, 2005 (in Japanese).
16. Higuchi M, Nishinaka H, Yamano Y. A case of chronic myeloid leukemia following TS-1 therapy for advanced gastric cancer. Jpn J Cancer Chemother 33: 2049-2052, 2006 (in Japanese, Abstract in English).
17. Waller CF, Fretscher S, Lange W. Treatment-related chronic myelogenous leukemia. Ann Hematol 78: 341-354, 1991.